Results 141 to 150 of about 11,407 (210)

Fitness cost of ceftazidime-avibactam resistance acquisition in carbapenem-resistant hypervirulent Klebsiella pneumoniae. [PDF]

BMC Microbiol
Huang M, Xiao SP, Zeng QH, Guo HM, Liu YT, Wei DD, Kang XH.   +6 more
europepmc   +1 more source

OmpK35/36 absence does not confer carbapenem-resistance alone nor ceftazidime-avibactam resistance with one <i>bla</i> _KPC-2. [PDF]

Front Cell Infect Microbiol
Wu S, Yang Y, Xiang W, Zhang J, Luo X, Xu M, Hu D, Zhang H.   +7 more
europepmc   +1 more source

Emergence of KPC-134, a KPC-2 variant associated with ceftazidime-avibactam resistance in a ST11 <i>Klebsiella pneumoniae</i> clinical strain. [PDF]

Microbiol Spectr, 2023
Huang X, Shen S, Chang F, Liu X, Yue J, Xie N, Yin L, Hu F, Xiao D.   +8 more
europepmc   +1 more source

Novel KPC-2 variants and epidemic ST463 clones underlie ceftazidime/avibactam resistance in carbapenem-resistant <i>Pseudomonas aeruginosa</i>. [PDF]

Microbiol Spectr
Hu Y, Sun Q, Shen W, Du J, Kaiqi Z, Zhang R.   +5 more
europepmc   +1 more source

Ceftazidime-avibactam resistance in Klebsiella pneumoniae sequence type 37: a decade of persistence and concealed evolution. [PDF]

Microb Genom, 2023
Arcari G, Polani R, Bruno F, Capitani V, Sacco F, Menichincheri G, Raponi G, Carattoli A.   +7 more
europepmc   +1 more source

Ceftazidime-Avibactam Resistance in Carbapenem-Resistant <i>Klebsiella pneumoniae</i> Bloodstream Infections: Risk Factors and Clinical Outcomes. [PDF]

Antibiotics (Basel)
Yanık A, Karaşahin Ö.
europepmc   +1 more source

Additional file 2 of Acetylcysteine increases sensitivity of ceftazidime-avibactam–resistant enterobacterales with different enzymatic resistance to ceftazidime-avibactam in vitro and in vivo

Additional file 2: Figure S2. ROS measurements of CZA-resistant DC7914, CG1090, and FK7018 after various treatments.
Huang, Zeyu, Han, Yijia, Zhang, Xiaotuan, Sun, Yao, Lin, Yuzhan, Feng, Luozhu, Zhou, Tieli, Wang, Zhongyong   +7 more
openaire   +1 more source

Rapid replacement of blaKPC variant in ST11 carbapenem-resistant and hypervirulent Klebsiella pneumoniae contributed to ceftazidime/avibactam resistance during severe in vivo infection. [PDF]

J Antimicrob Chemother
Yang P, Liu C, Zheng J, Yi J, Wu Z, Tian Y, Du P, Lu M, Shen N.   +8 more
europepmc   +1 more source

Emergence of Ceftazidime-Avibactam Resistance and Decreased Virulence in Carbapenem-Resistant ST11 Klebsiella pneumoniae During Antibiotics Treatment. [PDF]

Infect Drug Resist, 2022
Xu M, Qian C, Jia H, Feng L, Shi S, Zhang Y, Wang L, Cao J, Zhou T, Zhou C.   +9 more
europepmc   +1 more source

Global trends of ceftazidime-avibactam resistance in gram-negative bacteria: systematic review and meta-analysis. [PDF]

Antimicrob Resist Infect Control
Wang Y, Sholeh M, Yang L, Shakourzadeh MZ, Beig M, Azizian K.   +5 more
europepmc   +1 more source